Ausztria - angol - HMA (Heads of Medicines Agencies)

pfizer limited - canine adenovirus 4.9 gkid50, canine distemper virus 4.7 gkid50, canine parainfluenza virus 4.6 gkid50, canine parvovirus 6.1 gkid50, leptospira interrogans serogroup canicola 32 malr, leptospira interrogans serogroup icterohaemorragiae 32 malr, rabies virus, inactivated 2 iu - suspension for injection - dogs non food - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inact

Németország - angol - HMA (Heads of Medicines Agencies)

pfizer limited - canine adenovirus 4.9 gkid50, canine distemper virus 4.7 gkid50, canine parainfluenza virus 4.6 gkid50, canine parvovirus 6.1 gkid50, leptospira interrogans serogroup canicola 32 malr, leptospira interrogans serogroup icterohaemorragiae 32 malr, rabies virus, inactivated 2 iu - suspension for injection - dogs non food - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inact

Görögország - angol - HMA (Heads of Medicines Agencies)

pfizer limited - canine adenovirus 4.9 gkid50, canine distemper virus 4.7 gkid50, canine parainfluenza virus 4.6 gkid50, canine parvovirus 6.1 gkid50, leptospira interrogans serogroup canicola 32 malr, leptospira interrogans serogroup icterohaemorragiae 32 malr, rabies virus, inactivated 2 iu - suspension for injection - dogs non food - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inact

Franciaország - angol - HMA (Heads of Medicines Agencies)

pfizer limited - canine adenovirus 4.9 gkid50, canine distemper virus 4.7 gkid50, canine parainfluenza virus 4.6 gkid50, canine parvovirus 6.1 gkid50, leptospira interrogans serogroup canicola 32 malr, leptospira interrogans serogroup icterohaemorragiae 32 malr, rabies virus, inactivated 2 iu - suspension for injection - dogs non food - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inact

Magyarország - angol - HMA (Heads of Medicines Agencies)

pfizer limited - canine adenovirus 4.9 gkid50, canine distemper virus 4.7 gkid50, canine parainfluenza virus 4.6 gkid50, canine parvovirus 6.1 gkid50, leptospira interrogans serogroup canicola 32 malr, leptospira interrogans serogroup icterohaemorragiae 32 malr, rabies virus, inactivated 2 iu - suspension for injection - dogs non food - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inact

Portugália - angol - HMA (Heads of Medicines Agencies)

pfizer limited - canine adenovirus 4.9 gkid50, canine distemper virus 4.7 gkid50, canine parainfluenza virus 4.6 gkid50, canine parvovirus 6.1 gkid50, leptospira interrogans serogroup canicola 32 malr, leptospira interrogans serogroup icterohaemorragiae 32 malr, rabies virus, inactivated 2 iu - suspension for injection - dogs non food - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inact

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - rabies virus -

Írország - angol - HPRA (Health Products Regulatory Authority)

intervet ireland limited - rabies virus strain pasteur riv inactivated - suspension for injection - unknown - rabies virus vaccine - canine, feline - immunological - inactivated vaccine

Írország - angol - HPRA (Health Products Regulatory Authority)

intervet ireland limited - inactivated rabies virus antigen suspension - suspension for injection - 2-6 international units/dose - rabies virus - cats, dogs - immunological - inactivated vaccine

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - rabies virus, quantity: 2.5 iu - injection, powder for - excipient ingredients: monopotassium glutamate; trometamol; sodium chloride; disodium edetate; polygeline; sucrose - active immunisation against rabies virus, including a) pre-exposure immunisation b) post-exposure treatment following exposure to rabies virus.